







The increasing national focus on personalized or 'precision' medicine is misguided, distracting from broader investments to reduce health inequities and address the social factors that affect population health, two leading public health scholars argue. While investments in precision medicine may ultimately 'open new vistas of science,' enthusiasm about the promise of this research is premature, they say.
Want More Policies Based on Evidence?
Medicine teaches us it will take time, effort, and investment.

Precision Medicine in Neuroscience: Tools, Translation, and Implementation: A Workshop
Precision medicine approaches are rapidly transforming neuroscience, driven by advances in genetics, neuroimaging, biomarkers, and data science. These tools enable more refined disease classification, improved diagnosis, and treatments tailored to individual patients across neurological and psychiatric disorders. However, challenges remain in translating these advances into routine research and clinical practice. On March 4–5, the National Academies’ Forum on Neuroscience and Nervous System Disorders, in collaboration with the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health, will host a workshop exploring opportunities, challenges, and strategies for integrating precision medicine into neuroscience research and care.

Leading Innovation in Psychiatric Treatment | Alto Neuroscience
We leverage brain biology to develop personalized medicines, helping patients get better faster.

Home | Your Local Epidemiologist
Join 365k+ readers getting accurate, unfiltered, and easy-to-digest information on the rapidly changing public health landscape, so you can feel secure in making important health decisions for you and your family.
.png)
The Problem With Promoting ‘Gold Standard Science’
Opinion | Branding scientific research with a simplified label risks misleading the public and harming scientific literacy.

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change… | Samuel G. Rodriques | 491 comments
We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change that. Kosmos is now the first agent that can compress months of drug development into weeks, from the earliest stages of scientific discovery through to FDA approval. Incyte will be the first company to deploy it across their pipeline. Work that used to take a team of scientists months now happens in weeks. Patients can't wait, and neither can we. | 491 comments on LinkedIn
How the microbiome will lead a revolution in the consumerization of personalized medicine and diet | TechCrunch
The human microbiome -- meaning all of our microbes’ genes -- will reshape the consumerization of personalized medicine and diet. Following the human genome project, technological advancements have brought us much closer to acute precision in disease diagnosis and treatment. The microbiome has the potential to change the way we diagnose and treat the most critical diseases of our time.

Medicine Archives
See the latest Medicine stories from Popular Science. See news, trends, tips, reviews and more at Popular Science.
Home | Drug Science
Drug Science works to provide an evidence base free from political or commercial influence, creating the foundation for sensible and effective drug laws, and equipping the public, media and policy makers with the knowledge and resources to enact positive change.

Jason Shepherd on Twitter / X
I have quite a lot of thoughts on this..that won't fit in a tweet. Bottomline is that there are issues scientists in the US would love to improve - faster review, less grant writing, more stability and freedom to do risky science. The folks celebrating this doc are mostly../1 https://t.co/xlPAH9XYNC— Jason Shepherd (@JasonSynaptic) July 23, 2026
Get Curvy With Estradiol: Risks, Benefits, and Timeline - QueerDoc • Trans Online Doctors Office - Curing LGBTQ+ Healthcare Discrimination
However, we can only do so with some big caveats: we’re big into informed consent and evidence-based medicine, and, unfortunately, most of the research we

Nootropics - The Facts About "Smart Drugs" - Unfinished Man
Nootropics are a topic most have little knowledge of outside of scare articles in mass-market publications, and today I'm here to shed some light on them.

Sugar’s Sick Secrets
The sugar industry has driven decades of biased research that shirk sugar's responsibility for chronic disease. UCSF researchers are uncovering thousands of industry documents to combat this misinformation, and steer Americans away from what is becoming a growing health crisis.

The Risks of Industry Influence in Tech Research
Emerging information technologies like social media, search engines, and AI can have a broad impact on public health, political institutions, social dynamics, and the natural world. It is critical to develop a scientific understanding of these impacts to inform evidence-based technology policy that minimizes harm and maximizes benefits. Unlike most other global-scale scientific challenges, however, the data necessary for scientific progress are generated and controlled by the same industry that might be subject to evidence-based regulation. Moreover, technology companies historically have been, and continue to be, a major source of funding for this field. These asymmetries in information and funding raise significant concerns about the potential for undue industry influence on the scientific record. In this Perspective, we explore how technology companies can influence our scientific understanding of their products. We argue that science faces unique challenges in the context of technology research that will require strengthening existing safeguards and constructing wholly new ones.

The contract between science and society, plus a possible new Renaissance
Genomics may accomplish a lot, but could it redefine humanity's view of itself?

Honestly this is a low for @science.org, publishing a piece transparently pushing industry talking points and arguing humanity *and especially science* needs to be fundamentally altered to make their products work well. science.org/doi/10.1126/science.aem6470
In the image of their tools
www.science.org